Ray Therapeutics, Inc.
@raytherapeutics
Developing novel optogenetics gene therapies for patients with blinding diseases
ID: 1659294025386692608
18-05-2023 20:25:30
38 Tweet
49 Followers
30 Following
Congrats to Jenny Holt on being promoted to Chief Development Officer at Ray Therapeutics, Inc.! Following their impressive Series A, this signals serious growth lies ahead. businesswire.com/news/home/2023…
Our CEO Paul Bresge will be speaking on Oct 5 at Lotte NY Palace in NYC at 3 pm - Rewriting the Code: Navigating the Frontier of Gene & Cell Therapy Lei Lei Wu Endpoints News will be moderating the panel. Other panelists include JURA Bio, Inc. Aurion Biotech Immusoft Corporation Excision BioTherapeutics
Happy #NewMemberMonday! 🥼Experic Services is a CDMO focused on the needs of small, midsize & specialty pharmas 🏢KingStreetProperties removes real estate obstacles for science companies 👁️Ray Therapeutics, Inc. is on a mission to restore vision with the power of optogenetics
Our Chief Development Officer jenny holt speaks with BioProcess Online and Forge Biologics about #CDMOs and what’s constitutes a good partnership. Listen here: 👇👇👇 bioprocessonline.com/doc/cdmo-emerg…
Excited to announce we’ve been awarded $4M by California Institute for Regenerative Medicine to develop RTx-021 for the treatment of geographic atrophy age-related macular degeneration. Read the full release: businesswire.com/news/home/2023…
Ray Therapeutics secures $4M from CIRM to develop optogenetic therapy treatment for geographic atrophy Ray Therapeutics, Inc. #Funding #BioTech #Startups #optogenetics #CIRM #optogenetic #therapy #BreakingNews #Breaking techstartups.com/2023/11/13/ray…
🟢Cell therapy weekly: Ray Therapeutics, Inc. has been awarded US$4 million grant to advance optogenetic therapy Legend Biotech and Novartis form partnership a strategic partnership InGeneron reports positive data for rotator cuff tear cell therapy!
#BiotechShowcase2024 Agenda Highlight! Looking forward to this panel discussion w/ Kenneth Moch LifeSci Advisors, Paul Bresge Ray Therapeutics, Inc., Michael Margolis Oppenheimer & Co. Inc., Jack O'Meara, Regina Salvat Sofinnova Partners, & Nigel Sheail See full agenda here > hubs.la/Q02dNLQS0
💡JPM 2024 Featured Session with Jenny Holt (Ray Therapeutics, Inc.), Chris McDonald (Kite, a Gilead Company), A Gilead Company, Morten Sogaard (Astellas Gene Therapies), and Brian Riley (Beam Therapeutics) Register Here: lnkd.in/eTsmh7Pc #FierceJPMWeek #JPMWeek
#BiotechShowcase2024 Agenda Highlight! Looking forward to this panel discussion w/ Kenneth Moch LifeSci Advisors, Paul Bresge Ray Therapeutics, Inc., Michael Margolis Oppenheimer & Co. Inc., Jack O'Meara, Regina Salvat Sofinnova Partners, Nigel Sheail. See full agenda here > hubs.la/Q02f0vPm0
"You're going blind, there's nothing that can be done." Motivation for Paul Bresge to launch jCyte & Ray Therapeutics, Inc. to find cure for #retinitispigmentosa, the blinding disease his daughter Tamar was diagnosed with. Story by Mollie Barnes ✍🏻 in BioSpace biospace.com/article/how-a-…
Our Chief Development Officer Jenny Holt is speaking at LSX Leaders #LSXCongress in Boston today at 11 am ET. Check out the agenda: informaconnect.com/lsx-world-cong…
Our CEO Jenny Holt moderated a great session today at LSX Leaders in Boston. Thanks to all the panelists and everyone who attended the session!
